(2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

(2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo
Treatment and conditionWhere it standsTrials
(2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo for depressive disorder, treatment-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
(2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo for major depressive disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1